HD-OPM Archive
Topics › Brain health & dementia

Arginine reduced amyloid and inflammation in Alzheimer's mice and flies

Louis Nervegna · Nov 28, 2025 · ♥ 12 reactions · 3 comments · original Facebook post
Brain health & dementiaSupplements & vitamins
AI summary & key facts

Louis comments on a mouse and fruit-fly study where arginine reduced amyloid buildup and improved behavior. He cautions it may not translate to humans and that people who recently had a heart attack should not take arginine.

This is an interesting study in mice and flies. It may have no value at all in humans— but given the lack of effective treatments for Alzheimer’s, it might be worth a try.

Warning: People who have recently had a heart attack should NOT take arginine. See this post: ↪ Johns Hopkins arginine RCT stopped early: 6 deaths vs 0 in heart-attack survivors.

#arginineHD #alzheimersHD #dementiaHD

Research cited

Researchers gave arginine to mice and fruit flies engineered to develop Alzheimer’s-like pathology.
The result?

Far less amyloid buildup, fewer brain plaques, lower inflammation, and better behavior, even though the disease genes were still there.

Before you jump: this is NOT a human treatment.
These are animal and lab studies only.

But here’s why people are talking about it:
Alzheimer’s starts decades before symptoms, with proteins beginning to misfold and clump. Arginine seems to act like a “chemical chaperone,” keeping those proteins from sticking together in the first place.

If we can understand how nutrients or molecules do this in animals, we can design better human therapies that target the same early mechanism.

That’s the real story:
Not “arginine cures Alzheimer’s”…

but a safe, inexpensive molecule showing a repeatable mechanism that scientists can now chase in humans.

Doi: 10.1016/j.neuint.2025.106082

No photo description available.
← newer: L-arginine supplements can be dangerous after a heart attackolder: Metformin may work partly by reshaping the gut microbiome →